Taking FT671 as a lead compound, Cheng and collaborators synthesized a series of novel pyrrolo-pyrimidine derivatives and identified YCH2823 (Figure 9) as a potent USP7 inhibitor (IC50 = 0.50 μM) with a remarkable anti-proliferative impact on various tumor cells [182]. The gene discussed is USP7; the disease is neoplasm.